Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.balaxipharma.in | |
Market Cap | 431.71 Cr. | |
Enterprise Value(EV) | 450.45 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -10.35 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.37 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 144.55 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.92 | Calculated using Price: 422.00 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.02 Cr. | 10,230,200 Shares |
FaceValue | 10 | |
About Balaxi Pharmaceuticals Ltd. | ||
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products |
1 Day |
|
-0.34% |
1 Week |
|
+2.15% |
1 Month |
|
+0.55% |
3 Month |
|
-10.33% |
6 Month |
|
-19.41% |
1 Year |
|
-26.65% |
2 Year |
|
-19.04% |
5 Year |
|
+1380.70% |
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 55.84 | 39.04 | 82.26 | 53.50 | 32.17 | |
Return on Capital Employed (%) | 69.35 | 56.56 | 92.56 | 59.62 | 37.46 | |
Return on Assets (%) | 32.19 | 29.01 | 56.23 | 34.52 | 22.09 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4 | 28 | 65 | 113 | 183 | 155 | |
Non Curr. Liab. | 0 | 0 | 4 | 3 | |||
Curr. Liab. | 3 | 8 | 35 | 63 | 53 | 56 | |
Minority Int. | |||||||
Equity & Liab. | 6 | 36 | 100 | 176 | 240 | 214 | |
Non Curr. Assets | 0 | 1 | 6 | 35 | 46 | 51 | |
Curr. Assets | 6 | 35 | 94 | 141 | 194 | 163 | |
Misc. Exp. not W/O | |||||||
Total Assets | 6 | 36 | 100 | 176 | 240 | 214 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 14 | 46 | 231 | 279 | 336 | 288 | |
Other Income | 1 | 1 | 2 | 5 | 3 | -6 | |
Total Income | 14 | 46 | 234 | 284 | 339 | 282 | |
Total Expenditure | -12 | -37 | -189 | -229 | -279 | -240 | |
PBIDT | 2 | 9 | 45 | 56 | 60 | 42 | |
Interest | 0 | 0 | -1 | -1 | -1 | ||
Depreciation | 0 | 0 | -1 | -2 | -2 | ||
Taxation | 0 | -3 | -6 | -7 | -11 | -8 | |
Exceptional Items | -41 | ||||||
PAT | 2 | 6 | 38 | 48 | 46 | -11 | |
Minority Interest | |||||||
Share Associate | |||||||
Other Related Items | -1 | 1 | 6 | ||||
Consolidated Net Profit | 2 | 6 | 37 | 48 | 52 | -11 | |
Adjusted EPS | 6 | 6 | 37 | 48 | 51 | -10 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -2 | -14 | 34 | 6 | ||
Cash Fr. Inv. | 0 | 0 | -6 | -28 | -11 | |
Cash Fr. Finan. | 18 | 4 | 0 | 26 | ||
Net Change | -2 | 4 | -2 | 6 | 21 | |
Cash & Cash Eqvt | 0 | 4 | 2 | 7 | 28 |
Fri, 03 Nov 2023
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
|
|
Fri, 03 Nov 2023
Outcome of Board Meeting
|
|
Fri, 03 Nov 2023
Outcome of Board Meeting
|
Mon, 11 Dec 2023 |
|
|
|
|
|